PMID- 30015149 OWN - NLM STAT- MEDLINE DCOM- 20181015 LR - 20221207 IS - 1532-2688 (Electronic) IS - 1059-1311 (Linking) VI - 60 DP - 2018 Aug TI - Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis. PG - 163-171 LID - S1059-1311(18)30248-6 [pii] LID - 10.1016/j.seizure.2018.06.024 [doi] AB - PURPOSE: The aim of this study was to assess the association between human leukocyte antigen (HLA) variants and lamotrigine (LTG)-induced cutaneous adverse drug reactions (cARDs). METHODS: A comprehensive literature search was conducted on the relationship of HLA alleles with LTG-induced cADRs in Asian populations, through PubMed, Embase, and Cochrane Library. The last search was in February 2018. The pooled odds ratio (OR) with 95% confidence interval (95% CI) was used to access the strength of the association between an HLA allele and LTG-induced cADRs. RESULTS: A total of 11 studies met the inclusion criteria and were enrolled in our meta- analysis, which were based on Chinese, Korean, and Thai populations. Among these populations, we observed that HLA-B*1502 is a risk allele for LTG-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in Chinese populations (pooled OR 2.4, 95% CI: 1.20-4.78, P = 0.01), HLA-A*2402 was found to be a significant risk allele for both SJS/TEN (pooled OR 3.50, 95% CI: 1.61-7.59, P = 0.002) and maculopapular eruption (MPE) (pooled OR 2.14, 95% CI: 1.10-4.16, P = 0.03), and HLA-B*3303 was considered to be a protective marker for MPE in Chinese and Korean populations (pooled OR 0.2, 95% CI 0.06-0.64, P = 0.007). CONCLUSIONS: In Asian populations, HLA-B*1502 is a risk factor for LTG-induced bullous lesions such as SJS/TEN in Chinese populations, and HLA-A*2402 is associated with the susceptibility to either SJS/TEN or MPE. HLA-A*3303 is a protective allele against LTG-induced MPE in Chinese and Korean populations. CI - Copyright (c) 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. FAU - Deng, Yilun AU - Deng Y AD - Department of Neurology, West China Hospital of Sichuan University Chengdu, Sichuan 610041, China. FAU - Li, Shaoping AU - Li S AD - Department of Neurology, West China Hospital of Sichuan University Chengdu, Sichuan 610041, China. FAU - Zhang, Lin AU - Zhang L AD - Department of Neurology, West China Hospital of Sichuan University Chengdu, Sichuan 610041, China. FAU - Jin, Hou AU - Jin H AD - Department of Neurology, West China Hospital of Sichuan University Chengdu, Sichuan 610041, China. FAU - Zou, Xiaoyi AU - Zou X AD - Department of Neurology, West China Hospital of Sichuan University Chengdu, Sichuan 610041, China. Electronic address: xiaoyizou@scu.edu.cn. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review DEP - 20180707 PL - England TA - Seizure JT - Seizure JID - 9306979 RN - 0 (Anticonvulsants) RN - 0 (HLA Antigens) RN - 0 (Triazines) RN - U3H27498KS (Lamotrigine) SB - IM MH - Anticonvulsants/*adverse effects MH - Asian People/*genetics MH - HLA Antigens/*genetics MH - Humans MH - Lamotrigine MH - Pharmacogenomic Variants MH - Skin Diseases/*chemically induced/*genetics MH - Triazines/*adverse effects OTO - NOTNLM OT - HLA OT - Lamotrigine OT - Maculopapular eruption OT - Stevens-Johnson syndrome OT - Toxic epidermal necrolysis EDAT- 2018/07/18 06:00 MHDA- 2018/10/16 06:00 CRDT- 2018/07/18 06:00 PHST- 2018/04/18 00:00 [received] PHST- 2018/06/06 00:00 [revised] PHST- 2018/06/30 00:00 [accepted] PHST- 2018/07/18 06:00 [pubmed] PHST- 2018/10/16 06:00 [medline] PHST- 2018/07/18 06:00 [entrez] AID - S1059-1311(18)30248-6 [pii] AID - 10.1016/j.seizure.2018.06.024 [doi] PST - ppublish SO - Seizure. 2018 Aug;60:163-171. doi: 10.1016/j.seizure.2018.06.024. Epub 2018 Jul 7.